MUMBAI, India, Dec. 14, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in … Essentially, the Guardant360 test provides oncologists with CGP information that allows oncologists to see the most current profile of their patient's cancer, prescribe appropriate precision medicine, and recommend targeted treatment," said Supriya Lala, Best Practices Analyst from Frost & Sullivan. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. … node.dataset.value : node.getAttribute('data-value'); if (selectedValue) { for (var j = 0; j < node.options.length; j++) { if(node.options[j].value === selectedValue) { node.options[j].selected = 'selected';break;}}}}}, Do Not Sell My Personal Information (CA Residents Only). High near 30F. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has … ... Why ShockWave Medical, Novocure, and Guardant Health Shares Tanked Today. Location*Please select…United StatesAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, the Democratic Republic of theCook IslandsCosta RicaCôte d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, the former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesia, Federated States ofMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian Territory, OccupiedPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussian FederationRwandaSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofViet NamVirgin Islands (British)Virgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabwe. Since then, GH stock has increased by 100.1% and is now trading at $125.99. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Partly cloudy this evening with more clouds for overnight. "Guardant Health AMEA is at the forefront of precision oncology. This accolade is a testament to the success of the company's flagship liquid biopsy, the Guardant360® test, which oncologists are using to guide treatment decisions for advanced stage cancer patients. A simple blood draw helps cancer patients get the right drug. The MarketWatch News Department was not involved in the creation of this content. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Now FDA Approved. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. Success! A high-level overview of Guardant Health, Inc. (GH) stock. The company's patient-centric approach proactively addressed challenges associated with the COVID-19 pandemic, such as hospitals facing difficulties in scheduling tissue biopsies. Low 22F. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in terms of customer value and market penetration. Enter up to 25 symbols separated by spaces. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. Frost & Sullivan presents the Market Leadership Award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. You have permission to edit this article. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Guardant Health's companion diagnostic, the Guardant360® CDx test, for comprehensive tumor mutation profiling across all solid cancers, making it the first comprehensive liquid biopsy to receive U.S. FDA approval. Winds ENE at 10 to 20 mph. The stock has traded between $102.22 and $104.30 so far today. Cloudy with periods of snow during the afternoon. Prakash Rajapress@guardantamea.com www.guardanthealthamea.com. The Guardant Health oncology platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. Volume today is 704,441 compared to average volume of 840,411. Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, Novembe Guardant Health … Find real-time GH - Guardant Health Inc stock quotes, company profile, news and forecasts from CNN Business. MUMBAI, India, Dec. 14, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East and Africa (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. Available in 41 countries across AMEA, the company's Guardant360 test provides quick and accurate comprehensive genomic profiling (CGP) information from a simple blood draw in seven days upon sample receipt in the laboratory. Guardant Health Receives FDA Emergency Use Authorization For Its Guardant-19 Next Generation Sequencing-Based COVID-19 Test By GlobeNewswire Aug 24, 2020 8:05 AM EDT Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Low 22F. Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Error! Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. GH News Today (Guardant Health) | MarketBeat. Get up-to-the-minute news sent straight to your device. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. "This Frost & Sullivan Market Leadership award is an excellent tribute to my team's concerted efforts in advocating the Guardant360 test in Asia, Middle East and Africa. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its LUNAR development programs for recurrence and early detection. Get local Breaking News alerts sent directly to your inbox. Shares of Guardant Health (NASDAQ:GH) fell as much as 10.9% today after the company reported fourth-quarter and full-year 2019 operating results. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. I would like to receive Nasdaq communications related to Products, Industry News and Events.You can always change your preferences or unsubscribe and your contact information is covered by our Privacy Policy. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS Guardant Health (NASDAQ GH) News Headlines Today Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance )+)$)/i, failureMessage: "A valid email address is required"});field1.add(Validate.Format, {pattern: /\.\.|\. How Guardant Health is Supporting Cancer Care During the Pandemic. These symbols will be available throughout the site during your session. Partly cloudy this evening with more clouds for overnight. REDWOOD CITY, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today announced the closing of an underwritten public offering of 13,225,000 shares of its common stock at a public … Contact us: Start the discussion. The … Snow accumulating 3 to 5 inches. In many such instances, Guardant Health AMEA provides mobile phlebotomy services to cancer patients who are vulnerable to infection and assures undisrupted, on-time test report deliveries so that patients can start treatment without delay. The offering is expected to close on June 4. An email has been sent to with a link to confirm list signup. To screen for more stocks like Guardant Health Inc click here. X. Guardant Health … Soon, it could detect cancer earlier than ever before. Winds NE at 5 to 10 mph. © 2020, Nasdaq, Inc. All Rights Reserved. Follow a manual added link. … Health Details: Guardant Health, Inc. (NASDAQ:GH) Director Sells $55,968.14 in Stock americanbankingnews.com - October 28 at 6:01 PM: Guardant Health, Inc. (NASDAQ:GH) COO Amirali Talasaz Sells 13,136 Shares americanbankingnews.com - October 27 at 8:28 PM: Guardant Health, Inc. (NASDAQ:GH) COO Sells $484,457.26 in Stock … It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Winds NE at 5 to 10 mph.. Oncologists use this information to … Each year, Frost & Sullivan confers this award upon the company that demonstrates excellence in growth and customer value under the Best Practices category. Visit us online at www.guardanthealthamea.com. @/i, failureMessage: "A valid email address is required", negate: "true"});var dom2 = document.querySelector('#form1783 #field2');var field2 = new LiveValidation(dom2, {validMessage: "", onlyOnBlur: false, wait: 300});field2.add(Validate.Presence, {failureMessage:"This field is required"});var dom5 = document.querySelector('#form1783 #field5');var field5 = new LiveValidation(dom5, {validMessage: "", onlyOnBlur: false, wait: 300});field5.add(Validate.Custom, {against: function(value) {return !value.match(/(telnet|ftp|https?):\/\/(?:[a-z0-9][a-z0-9-]{0,61}[a-z0-9]\.|[a-z0-9]\. Tarini Singh P: +91-20 6718 9725 E: Tarini.Singh@frost.com. The latest development is the acquisition of Grail by Illumina, meaning the maker of the gene sequencing machines Guardant Health uses will be … Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. More About Guardant Health Inc. Guardant Health Inc is a precision oncology company. The Guardant360 test is providing CGP information across all solid cancers, while most competing liquid biopsies only focus on single or selected cancer genes. Chance of snow 80%. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time . There was an error processing your request. Guardant Health AMEA today announces the launch of its Asia, Middle East and Africa headquarters in Singapore with the goal of addressing the unmet medical need in cancer management by leveraging comprehensive genomic profiling liquid… Create your Watchlist to save your favorite quotes on Nasdaq.com. Guardant Health AMEA is breaking boundaries in advanced cancer diagnostics beyond invasive tissue biopsies, which are considered globally as the standard of care. Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Oct. 16, 2020- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020 . Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. I would like to take this opportunity to acknowledge all the oncologists who have been ordering our test, our channel partners for their steadfast support and most importantly, the patients who have made Guardant360 their liquid biopsy of choice," said Simranjit Singh, Chief Executive Officer of Guardant Health AMEA. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. Guardant Health News: This is the News-site for the company Guardant Health on Markets Insider. Touch device users, explore by touch or with swipe gestures. Guillermo’s Story. Attaining loyal customers that become brand advocates allows the company to grow and achieve a market leadership position. Since its launch in 2014, Guardant360 has been ordered by more than 7,000 oncologists and over 60 biopharmaceutical companies. var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /(^[A-Z0-9!#$%&'\*\+\-\/=\?\^_`\{\|\}~][A-Z0-9!#$%&'\*\+\-\/=\?\^_`\{\|\}~\.]{0,62}@(([A-Z0-9](?:[A-Z0-9\-]{0,61}[A-Z0-9])?)(\.[A-Z0-9](?:[A-Z0-9\-]{0,61}[A-Z0-9])? Guardant Health on Monday announced that the FDA gave emergency use authorization for its coronavirus test.GH stock rose near a buy point on the news before slipping. )+[a-z]{2,63}/i);}, failureMessage: "Value must not contain any URL's"});field5.add(Validate.Presence, {failureMessage:"This field is required"});field5.add(Validate.Length, {tooShortMessage:"Invalid length for field value", tooLongMessage: "Invalid length for field value", minimum: 4, maximum: 4});function handleFormSubmit(ele) { var submitButton = ele.querySelector('input[type=submit]'); var spinner = document.createElement('span'); spinner.setAttribute('class', 'loader'); submitButton.setAttribute('disabled', true); submitButton.style.cursor = 'wait'; submitButton.parentNode.appendChild(spinner); return true; }function resetSubmitButton(e){ var submitButtons = e.target.form.getElementsByClassName('submit-button'); for(var i=0;i